Opioid receptors

Continuing Education in Anaesthesia, Critical Care and Pain

Volumn 5, Issue 1, 2005, Pages 22-25

  McDonald, John ^a   Lambert, D G ^a  

^a LEICESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 24044443251     PISSN: 17431816     EISSN: 17431824     Source Type: Journal    
DOI: 10.1093/bjaceaccp/mki004     Document Type: Article

References (8)

1. Hughes J, Smith TW, Kosterlitz HW, Fothergill LA, Morgan BA, Morris HR. Identification of two related pentapeptides from the brain with potent opiate agonist activity. Nature 1975; 258: 577-80
2. Dhawan BN, Cesselin F, Raghubir R, et al. International Union of Pharmacology. XII. Classification of opioid receptors. Pharmacol Rev 1996; 48: 567-92
3. Analgesic drugs. In: Rang HP, Dale MM, Ritter JM, eds. Pharmacology, 4th Edn. Churchill Livingston, 1995; 589-602
4. Mogil JS, Grisel JE. Transgenic studies of pain. Pain 1998; 77: 107-28
5. Akil H, Owens C, Gutstein H, Taylor L, Curran E, Watson S. Endogenous opioids: overview and current issues. Drug Alcohol Depend 1998; 51: 127-40
6. Wadenberg ML. A review of the properties of spiradoline: a potent and selective kappa-opioid receptor agonist. CNS Drug Rev 2003; 9: 187-98
7. Walsh SL, Strain EC, Abreu ME, Bigelow GE, Wadenberg ML. Enadoline, a selective kappa opioid agonist: comparison with butorphanol and hydromorphone in humans, a review of the properties of spiradoline: a potent and selective kappa-opioid receptor agonist. Psychopharmacology (Berl) 2001; 157: 151-62
8. Pan Z, Hirakawa N, Fields HL. A cellular mechanism for the bidirectional pain-modulating actions of orphanin FQ/nociceptin. Neuron 2000; 26: 515-22